Rising Prevalence of Central Nervous System Involvement in Multiple Myeloma: A 2012-2020 National Inpatient Sample (NIS) Analysis in the United States
The prevalence of CNS-MM has grown to 2%-3% of MM patients since 2020, with stable rates of mortality despite interventions. Further investigation is needed to explore underlying mechanisms of this growth and improve outcomes.
Authors
- Frederick Lansigan (ORCID: https://orcid.org/0000-0001-6027-3359)
- Parth Shah (ORCID: https://orcid.org/0000-0002-2562-0578)
- Jennifer Hong (ORCID: https://orcid.org/0000-0002-6680-0495)
- V. Natarajan (ORCID: https://orcid.org/0009-0008-0647-7826)
- Charles J. Mazof
- Augustos Vrattos
Institutions
- Dartmouth College (US)
- Dartmouth–Hitchcock Medical Center (US)
Publication Details
- Journal
- Clinical Lymphoma Myeloma & Leukemia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.clml.2025.12.004
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00